AI News Hub
TodayNewsToolsIdeasTrends
Admin

The AI brief, in your inbox

One email. The morning brief, new tools and where AI is heading — free.

AI News Hub — Daily AI news, tools, trends and ideas, curated by ClaudeNews every 30 min · tools, trends & ideas daily at 5amRSS
All tools
Researchby Hemispheric
Descartes (AI Model by Hemispheric) logo

Descartes (AI Model by Hemispheric)

Free

Foundation AI model for decoding non-invasive brain activity to diagnose neurological and psychiatric disorders

Descartes is a 6-billion-parameter frontier NeuroAI foundation model that translates electrical brain signals into quantitative, objective insights for clinicians and researchers. Trained on over 250,000 hours of EEG and behavioral data from more than 100,000 participants, it decodes brain activity without invasive procedures to help diagnose conditions like depression, PTSD, Parkinson's disease, anxiety, schizophrenia, and early cognitive decline. During a 15-minute session, patients wear a lightweight dry-electrode EEG headset while interacting with an app, enabling objective brain measurements comparable to blood tests or ECGs for other organs.

Who it's for

Clinicians and psychiatristsNeuroscientists and researchersPharmaceutical companiesHealthcare organizationsDiagnostic centers

Pricing · enterprise

checked today
PlanPriceIncludes
B2B EnterpriseFreeAvailable through partnerships with healthcare organizations, pharmaceutical companies, and government agencies · No public pricing disclosed; licensing model for clinical and research use

AI-researched pricing — verify on the official site before subscribing.

Use it for

  • — Objective diagnosis of depression, PTSD, and other neuropsychiatric disorders
  • — Treatment selection and monitoring in clinical settings
  • — Drug development and clinical trials for neurological conditions
  • — Early detection and prediction of Alzheimer's disease
  • — Precision brain health diagnostics
  • — Research on brain function and neural biomarkers

Get the most out of it

  1. 01The technology is still in regulatory approval phase (FDA submission planned for early 2027) so clinical availability is limited; focus current engagement on research partnerships or pharmaceutical trials
  2. 02Descartes requires specialized EEG hardware and app-based tasks; integration with existing clinical workflows will require infrastructure investment
  3. 03Leverage the 250,000+ hours of training data and 6-billion-parameter model for complex brain interpretation; the model's strength is comparing individual brain patterns across populations
  4. 04Work with Hemispheric's team on custom implementations since this is an enterprise platform; direct partnerships offer better ROI than generic deployments
  5. 05Position Descartes as an objective diagnostic tool to replace subjective questionnaires; emphasize the potential to reduce trial-and-error treatment selection cycles
Visit Descartes (AI Model by Hemispheric)
Was this useful?